Exhibit
99.1

FOR
IMMEDIATE RELEASE
Deep
Isolation Nuclear, Inc. Reports Operational and Financial Results for the Third Quarter of 2026
Operational
Highlights for the Third Quarter of 2026
| ● | Common
stock approved for quotation and began trading on the OTCQB Venture Market under the ticker
symbol “DBHL” in July 2026 |
| ● | Selected
as the sole industrial partner on three U.S. Department of Energy (“DOE”) Project
GENESIS grants advancing artificial intelligence-enabled nuclear waste repository analysis |
| ● | Announced
results from a three-year DOE-funded study evaluating deep borehole disposal of waste generated
by recycling used nuclear fuel |
| ● | Subsequent
to quarter-end, published customer case study with Slovenia’s Agency for Radio Active Waste
Management highlighting the potential cost and operational benefits of Deep Isolation’s deep
borehole disposal approach |
| ● | Subsequent
to quarter-end, announced receipt of a drilling permit from the Texas Railroad Commission
for the Company’s full-scale, non-radioactive Commercialization Pilot near Cameron, Texas |
| ● | Subsequent
to quarter-end, began site preparation, including well pad construction for the full-scale,
non-radioactive Commercialization Pilot near Cameron, Texas |
Financial
Highlights for the Third Quarter of 2026
| ● | Reported
consolidated revenue of $1.8 million |
| ● | Reported
research and development expense of approximately $0.5 million related to the non-radioactive,
full-scale, at-depth demonstration of the Company’s deep borehole waste disposal technology |
| ● | Had
available cash of $16.5 million as of September 30, 2026 |
| ● | Reported
a net loss of $3.8 million primarily attributable to research and development and selling,
general, and administrative expenses |
| ● | Total
common shares outstanding as of November 9, 2026 of
57,765,606 |
PLANO,
TX, November 12, 2026 – Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation”
or the “Company”), a leading innovator in nuclear waste disposal technology, today announced its operational and financial
results for the three months ended September 30, 2026.
“The
third quarter advanced our work toward commercial readiness,” said Rod Baltzer, CEO of Deep Isolation. “We announced results
from a three-year DOE-funded study evaluating a permanent disposal pathway for waste from recycled nuclear fuel, and we continued to
advance our full-scale, non-radioactive Commercialization Pilot near Cameron, Texas. Subsequent to quarter-end, receipt of the drilling
permit from the Texas Railroad Commission and the start of well pad construction marked further steps toward field execution.
“Additionally,
our common stock began trading on the OTCQB Venture Market in July, and we were selected as the sole industrial partner on three DOE
Project GENESIS grants focused on artificial intelligence-enabled repository analysis. We believe the industry’s growing attention
to the full nuclear fuel cycle reinforces the importance of developing practical permanent nuclear waste disposal solutions. Our focus
remains on demonstrating our technology and working with customers and collaborators to advance its commercial adoption.”
Operational
Progress
During
the third quarter, Deep Isolation continued engineering and procurement activities for its non-radioactive, full-scale, at-depth demonstration
of its deep borehole disposal technology (the “Commercialization Pilot”) at the Deep Borehole Demonstration Center (“DBDC”),
located at Halliburton’s Drilling Technology Facility near Cameron, Texas. The program is designed to test borehole construction,
surface handling, and full-scale emplacement and retrieval of the Company’s Universal Canister System (“UCS”). Subsequent
to quarter-end, on October 1, 2026, the Company announced that the Texas Railroad Commission had issued a drilling permit, allowing the
project to advance toward construction and field activities. The permit is for the non-radioactive pilot and does not authorize disposal
of radioactive waste.
On
October 28, 2026, the Company announced that site preparation, including well pad construction, had begun at the DBDC. The pad will support
drilling, casing and cementing operations for the demonstration borehole as part of the Commercialization Pilot. The Commercialization
Pilot is being conducted in collaboration with the DBDC, Halliburton, Amentum, NAC International and Occlusion Nuclear Solutions, using
non-radioactive packages to simulate repository operations.
Commercial
Progress and Other Company Events
In
July 2026, the Company’s common stock was approved for quotation on the OTCQB Venture Market under the symbol “DBHL.”
On July 23, 2026, Deep Isolation was selected as the sole industrial partner on three competitive grants under DOE’s Project GENESIS
program. Two projects are led by Lawrence Berkeley National Laboratory and one by the University of South Carolina, advancing artificial
intelligence-enabled repository site screening, design and performance analysis.
On
September 22, 2026, Deep Isolation announced results from a three-year DOE-funded project under ARPA-E’s CURIE program, conducted
with Argonne National Laboratory, Oklo and Case Western Reserve University. Deep Isolation evaluated packaging, repository design, long-term
safety and economics for disposal of waste from recycled nuclear fuel. All disposal scenarios studied were projected to cost less than
the program’s target of 0.1 cent per kilowatt-hour of electricity generated, and all scenarios under expected conditions met the
study’s safety performance criteria.
Subsequent
to quarter-end, on October 14, 2026, the Company published a customer case study featuring Slovenia’s Agency for Radioactive Waste
Management. The assessment compared a standalone disposal facility for TRIGA II research-reactor spent fuel with integration into a proposed
deep borehole repository for Krško Nuclear Power Plant spent fuel. The analysis found that integrating the smaller inventory could
increase total repository lifecycle costs by less than approximately 0.5%, illustrating the potential benefits of shared disposal infrastructure.
Nuclear
Industry Developments
Permanent
nuclear waste disposal remained central to discussions of a sustainable nuclear fuel cycle during the third quarter and subsequent to
quarter-end. In the United States, the Department of Energy continued exploring Nuclear Lifecycle Innovation Campuses through voluntary
federal-state partnerships that could co-locate enrichment, fuel fabrication, used-fuel reprocessing and waste disposition. Utah, Tennessee,
Oklahoma, Louisiana and Idaho signed memoranda of understanding in July. These agreements represent continued exploration of potential
host sites, rather than authorization to construct or operate a repository. The initiative highlights the importance of considering permanent
disposal alongside investment in nuclear generation and fuel recycling.
Internationally,
Finland advanced toward permanent nuclear waste disposal in a mined repository when its nuclear safety regulator issued a favorable safety
assessment in August. Subsequent to quarter-end, on October 22, the Finnish Government granted Posiva an operating license for its spent-fuel
encapsulation and final disposal facility at Olkiluoto, the first such license for a mined repository worldwide. Commissioning tests,
inspections and regulatory approvals remain necessary before production operations begin. Fuel-cycle innovation also continued in the
United States: in October, ARPA-E selected eight projects for award negotiations under its HORNIG program focused on advanced reactor
fuels and the use of recycled nuclear materials. In management’s view, recycling and permanent disposal are complementary elements
of long-term waste management, including disposal of the residual waste generated by recycling.
Broader
nuclear investment continued to reflect demand for reliable electricity, including from artificial intelligence and data centers. Subsequent
to quarter-end, Google and Constellation announced a 20-year power purchase agreement on October 6 intended to enable 890 megawatts of
additional nuclear capacity through upgrades at 11 existing reactor units. Such investments illustrate the role of existing nuclear facilities
in meeting growing power demand while advanced reactor technologies progress toward deployment. In management’s view, continued
operation of existing reactors, new nuclear capacity and investment in fuel recycling could expand the long-term need for permanent disposal
solutions. Realizing that opportunity will depend on successful technology demonstration, licensing, financing, community engagement
and, in the United States, legislative changes needed to allow commercialization of deep borehole disposal.
Financial
Summary
| | |
For the Three Months Ended | |
| (Amounts in thousands) | |
9/30/2026 | | |
9/30/2025 | |
| Revenue | |
$ | 1,787 | | |
$ | 1,683 | |
| Research and development expense | |
| 450 | | |
| — | |
| Selling, general and administrative expenses | |
| 4,326 | | |
| 2,493 | |
| Net Loss | |
| (3,764 | ) | |
| (1,307 | ) |
| EBITDA1 | |
| (3,819 | ) | |
| (1,510 | ) |
| Adjusted EBITDA1 | |
| (3,369 | ) | |
| (1,410 | ) |
| Cash (as of) | |
| 16,540 | | |
| 28,209 | |
Revenue
increased by approximately $0.1 million, or 6%, for the three months ended September 30, 2026, compared to the three months ended
September 30, 2025. The increase in revenue was primarily attributable to completion milestones achieved for certain projects at
Deep Isolation along with increased billing at existing projects at Freestone Environmental Services, Inc. (“Freestone”), the
Company’s wholly owned environmental consulting subsidiary.
Research
and development expense increased by approximately $0.5 million for the three months ended September 30, 2026, compared to the three
months ended September 30, 2025. The increase in research and development expense was attributed to the ordering of long-lead items
and front-end engineering work related to the Company’s non-radioactive, full-scale, at-depth demonstration of its deep borehole disposal
technologies.
Selling,
general and administrative expenses increased by approximately $1.8 million, or 74%, for the three months ended September 30, 2026,
compared to the three months ended September 30, 2025. The increase in selling, general and administrative expenses was primarily
attributable to stock-based compensation along with higher employee and benefits expenses following the addition of 9 new employees since
the beginning of 2026, including the Chief Financial Officer and General Counsel.
Net
loss increased by $2.5 million
for the three months ended September 30, 2026,
compared to the three months ended September 30, 2025, primarily due to the increases in research and development and selling,
general and administrative expenses described above.
EBITDA1
was a loss of 3.8 million for
the three months ended September 30, 2026, compared to a loss of 1.5 million
for the three months ended September 30, 2025.
The decrease in EBITDA was primarily attributed to higher research and development expenses and selling, general, and administrative
expenses as described above.
Adjusted
EBITDA1 was a loss of $3.4 million for
the three months ended September 30, 2026, compared to $1.4 million for
the three months ended September 30, 2025. The decrease in Adjusted EBITDA was primarily
attributed to higher selling, general, and administrative expenses as described above.
About
Deep Isolation
Deep
Isolation (OTCQB: DBHL) is the first company to undertake development of technologies for nuclear waste disposal in deep boreholes. Deep
Isolation’s solution is designed to offer a unique approach to help countries identify, plan for and complete the necessary steps
to dispose of their nuclear waste inventories. With over 100 patents issued to date, Deep Isolation’s technology is designed to
leverage proven drilling practices to allow safe isolation of waste deep underground in horizontal, vertical, or slanted borehole repositories.
Deep Isolation’s Universal Canister System is engineered to support integrated management of spent fuel and high-level radioactive
waste from legacy and advanced reactors across storage, transportation, and eventual disposal. In January 2026, Deep Isolation launched
a full-scale, at-depth deep borehole Commercialization Pilot for its solution at Cameron, Texas, in collaboration with the Deep Borehole
Demonstration Center, Halliburton (NYSE: HAL), Amentum (NYSE: AMTM), NAC International (TYO: 7004), and Occlusion Nuclear Solutions.
| 1 |
EBITDA and Adjusted EBITDA are non-GAAP
financial measures and should not be used in isolation or as a substitute for Deep Isolation’s financial results presented in accordance
with Generally Accepted Accounting Principles (“GAAP”). For the definitions and reconciliations of these measures to the most
directly comparable financial measures calculated and presented in accordance with GAAP, please refer to Exhibit II at the end of this
press release |
For
more information, visit: deepisolation.com
Media
Contact:
Sophie
McCallum
media@deepisolation.com
Investor
Contact:
Caldwell
Bailey
ICR,
Inc.
InvestorRelations@deepisolation.com
Forward-Looking
Statements
Statements
contained in this press release that are not historical facts are “forward-looking information” or “forward-looking
statements” (collectively, “forward-looking statements”) within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not
limited to, statements regarding our plans, objectives and expectations for our business, the future growth of our business and the nuclear
energy and nuclear waste disposal industries as a whole, the Commercialization Pilot, and future benefits expected to arise from our
strategic partnerships. In certain cases, forward-looking statements can be identified by the use of words and phrases or variations
of words and phrases or statements such as “may,” “should,” “expect,” “intend,” “plan,”
“anticipate,” “believe,” “estimate,” “predict,” “will,” “could,”
“project,” “target,” “potential,” “continue” and similar expressions. Forward-looking
statements are based on management’s belief and assumptions, including current expectations and projections about future events
and trends, and on information currently available to management.
Forward-looking
statements in this or any other news release are subject to a number of risks, uncertainties, and assumptions that could cause actual
results to be materially different from those expressed or implied by such forward-looking statements. Such risks, uncertainties, and
assumptions are subject to a number of factors, including, among others: the failure of a market to develop for our deep borehole disposal
solutions as quickly as we expect or at all; a failure of demand for our solution to develop sufficiently; regulatory and legal developments,
including issues relating to obtaining regulatory approvals or permissions on the timelines we expect or at all; our lack of profitability;
delays or failure in our initiative to complete a full-scale, at-depth demonstration of our Universal Canister System and our deep borehole
solution; our failure to enter into contracts with customers or, once we do enter into contracts, to continue such contractual relationships
or to receive new contract awards; our dependency on governmental contracts and awards and our ability to finalize negotiations on same;
our failure to manage our growth effectively or to execute our business plan; our failure to sustain and expand relationships with governmental
entities and strategic partners; a failure in the assumptions or analyses we have used in supporting forecasts or plans; our inability
to commercialize our products at scale; the development or deployment of other technologies or solutions supplanting or competing with
our technologies; challenges to our intellectual property; failures to protect, maintain, enforce, and enhance our intellectual property,
and claims by others of intellectual property infringement; political and public perceptions of nuclear energy, including perceptions
as to accidents or other high-profile events involving nuclear power facilities or radioactive materials; our liquidity and ability to
raise capital; any inability to control operating and project costs and project delays or other project-related problems; security (including
cybersecurity) breaches or disruptions; geopolitical, macroeconomic, domestic events or crises, including supply chain disruptions and
other risks and uncertainties outside of our control; weather and effects of climate change; and litigation or legal proceedings that
may be brought against us.
The
foregoing is not an exhaustive list of all the factors that may cause any forward-looking statements to prove inaccurate or our actual
results to differ materially from our expectations and forecasts. Moreover, we operate in a highly regulated environment. New risks emerge
from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business
or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any
forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed
in this release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking
statements, and we cannot guarantee future results, performance, or achievements. Accordingly, readers should not place undue reliance
on forward-looking statements. We undertake no obligation to update any forward-looking statements for any reason after the date of this
press release or to conform these statements to actual results or revised expectations, except as required by law. Additional information
concerning the factors above and other factors will be found in the Company’s public filings with the Securities and Exchange Commission
(the “SEC”), including the sections titled “Forward-Looking Statements” and “Risk Factors” in the
Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on March 30, 2026, its Quarterly
Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, filed with the SEC on May 15, 2026 and August 7, 2026,
respectively, our Registration Statement Form S-1, originally filed August 18, 2025 and subsequently amended, our Proxy Statement for
our 2026 Annual Meeting of Stockholders as filed on April 29, 2026, and in filings with the SEC that will be made in the future.
The
Company’s SEC filings are available free of charge at www.sec.gov or upon written request to Deep Isolation at InvestorRelations@deepisolation.com
or CorpSec@deepisolation.com.
Exhibit
I - Unaudited Interim Financial Information
Deep
Isolation Nuclear, Inc. and Subsidiaries
Condensed
Consolidated Balance Sheets
(in
thousands, except share and per share data)
| | |
September 30, 2026 (Unaudited) | |
December 31, 2025 |
| Assets | |
| |
|
| Current assets: | |
| |
|
| Cash | |
$ | 16,540 | | |
$ | 27,434 | |
| Accounts receivable, net of allowance for credit losses of $135 and $118, respectively | |
| 769 | | |
| 439 | |
| Contract assets | |
| 873 | | |
| 275 | |
| Other current assets | |
| 836 | | |
| 672 | |
| Total current assets | |
| 19,018 | | |
| 28,820 | |
| | |
| | | |
| | |
| Property, plant and equipment, net | |
| 193 | | |
| 128 | |
| Intangible assets, net | |
| 13 | | |
| 73 | |
| Finance lease right-of-use assets | |
| 9 | | |
| 11 | |
| Operating lease right-of-use assets | |
| 178 | | |
| 269 | |
| Goodwill | |
| 182 | | |
| 182 | |
| Other non-current assets | |
$ | 72 | | |
$ | 140 | |
| Total assets | |
$ | 19,665 | | |
$ | 29,623 | |
| | |
| | | |
| | |
| Liabilities and Stockholders’ Equity | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Accounts payable | |
$ | 749 | | |
$ | 1,113 | |
| Accrued payroll | |
| 316 | | |
| 774 | |
| Contract liabilities | |
| 225 | | |
| 150 | |
| Finance lease liabilities, current | |
| 3 | | |
| 3 | |
| Operating lease liabilities, current | |
| 136 | | |
| 125 | |
| Other current liabilities | |
| 390 | | |
| 101 | |
| Total current liabilities | |
| 1,819 | | |
| 2,266 | |
| | |
| | | |
| | |
| Finance lease liabilities, net of current portion | |
| 6 | | |
| 9 | |
| Operating lease liabilities, net of current portion | |
| 48 | | |
| 152 | |
| Total liabilities | |
| 1,873 | | |
| 2,427 | |
| Commitments and Contingencies (Note 16) | |
| | | |
| | |
| Stockholders’ Equity | |
| | | |
| | |
| Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 57,726,850 and 57,542,113 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |
| 6 | | |
| 6 | |
| Additional paid-in capital | |
| 62,244 | | |
| 59,456 | |
| Accumulated deficit | |
| (44,719 | ) | |
| (32,503 | ) |
| Accumulated other comprehensive income | |
| 261 | | |
| 237 | |
| Total stockholders’ equity | |
| 17,792 | | |
| 27,196 | |
| Total liabilities and stockholders’ equity | |
$ | 19,665 | | |
$ | 29,623 | |
Deep
Isolation Nuclear, Inc. and Subsidiaries
Condensed
Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
(in thousands, except share and per share data)
| | |
Three Months Ended September 30, | |
Nine Months Ended September 30, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| | |
| |
| |
| |
|
| Revenue | |
$ | 1,787 | | |
$ | 1,683 | | |
$ | 4,553 | | |
$ | 4,837 | |
| Cost of services (exclusive of depreciation shown separately below) | |
| (830 | ) | |
| (700 | ) | |
| (2,123 | ) | |
| (2,118 | ) |
| Gross profit | |
| 957 | | |
| 983 | | |
| 2,430 | | |
| 2,719 | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating expenses: | |
| | | |
| | | |
| | | |
| | |
| Selling, general and administrative expenses | |
| 4,326 | | |
| 2,493 | | |
| 9,912 | | |
| 5,701 | |
| Research and development | |
| 450 | | |
| — | | |
| 5,119 | | |
| — | |
| Depreciation and amortization expense | |
| 36 | | |
| 29 | | |
| 86 | | |
| 88 | |
| Total operating expenses | |
| 4,812 | | |
| 2,522 | | |
| 15,117 | | |
| 5,789 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss from operations | |
| (3,855 | ) | |
| (1,539 | ) | |
| (12,687 | ) | |
| (3,070 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Gain on insurance settlement | |
| — | | |
| — | | |
| 27 | | |
| — | |
| Other income | |
| 91 | | |
| 232 | | |
| 444 | | |
| 235 | |
| Net loss before income taxes | |
| (3,764 | ) | |
| (1,307 | ) | |
| (12,216 | ) | |
| (2,835 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Provision for income taxes | |
| — | | |
| — | | |
| — | | |
| 1 | |
| Net loss | |
$ | (3,764 | ) | |
$ | (1,307 | ) | |
$ | (12,216 | ) | |
$ | (2,836 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Other comprehensive income (loss): | |
| | | |
| | | |
| | | |
| | |
| Foreign currency translation adjustments | |
| (9 | ) | |
| 160 | | |
| 24 | | |
| 120 | |
| Total other comprehensive income (loss) | |
| (9 | ) | |
| 160 | | |
| 24 | | |
| 120 | |
| Net loss and other comprehensive loss | |
$ | (3,773 | ) | |
$ | (1,147 | ) | |
$ | (12,192 | ) | |
$ | (2,716 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss per common share – basic and diluted | |
$ | (0.07 | ) | |
$ | (0.02 | ) | |
$ | (0.21 | ) | |
$ | (0.06 | ) |
| Weighted average common shares outstanding - basic and diluted | |
| 57,691,306 | | |
| 54,260,091 | | |
| 57,660,360 | | |
| 45,750,667 | |
Deep
Isolation Nuclear, Inc. and Subsidiaries
Condensed
Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)
(in thousands, except share and per share data)
| | |
Common
Stock | | |
Preferred
Stock Series
A | | |
Preferred
Stock Series A Prime | | |
Additional Paid
in | | |
Accumulated | | |
Accumulated Other Comprehensive | | |
Total Stockholders’ | |
| | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Income | | |
Equity | |
| Balance,
January 1, 2025 | |
| 773,941 | | |
$ | — | | |
| 655,351 | | |
$ | — | | |
| 115,057 | | |
$ | — | | |
$ | 29,962 | | |
$ | (27,167 | ) | |
$ | 122 | | |
$ | 2,917 | |
| Retroactive
application of Merger | |
| 39,127,838 | | |
| 4 | | |
| (655,351 | ) | |
| — | | |
| (115,057 | ) | |
| — | | |
| (4 | ) | |
| — | | |
| — | | |
| — | |
| Adjusted
Balance beginning of quarter | |
| 39,901,779 | | |
$ | 4 | | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | 29,958 | | |
$ | (27,167 | ) | |
$ | 122 | | |
$ | 2,917 | |
| Exercise
of stock options | |
| 1,330,620 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 70 | | |
| — | | |
| — | | |
| 70 | |
| Stock
based compensation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 25 | | |
| — | | |
| — | | |
| 25 | |
| Foreign
currency translation adjustments | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (50 | ) | |
| (50 | ) |
| Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (166 | ) | |
| — | | |
| (166 | ) |
| Balance,
March 31, 2025 | |
| 41,232,399 | | |
| 4 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 30,053 | | |
| (27,333 | ) | |
| 72 | | |
| 2,796 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercise
of stock options | |
| 2,737,355 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 324 | | |
| — | | |
| — | | |
| 324 | |
| Stock
based compensation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 30 | | |
| — | | |
| — | | |
| 30 | |
| Foreign
currency translation adjustments | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 10 | | |
| 10 | |
| Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,363 | ) | |
| — | | |
| (1,363 | ) |
| Balance,
June 30, 2025 | |
| 43,969,754 | | |
| 4 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 30,407 | | |
| (28,696 | ) | |
| 82 | | |
| 1,797 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercise
of stock options | |
| 304,545 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 40 | | |
| — | | |
| — | | |
| 40 | |
| Stock
based compensation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 192 | | |
| — | | |
| — | | |
| 192 | |
| Shares
issued in reverse acquisition | |
| 2,250,000 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (176 | ) | |
| — | | |
| — | | |
| (176 | ) |
| Treasury
Stock | |
| (26,870 | ) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (81 | ) | |
| — | | |
| — | | |
| (81 | ) |
| Shares
issued in private placement offering, net of offering costs | |
| 11,012,387 | | |
| 1 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 28,847 | | |
| — | | |
| — | | |
| 28,848 | |
| Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 160 | | |
| 160 | |
| Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,307 | ) | |
| — | | |
| (1,307 | ) |
| Balance,
September 30, 2025 | |
| 57,509,816 | | |
$ | 5 | | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | 59,229 | | |
$ | (30,003 | ) | |
$ | 242 | | |
$ | 29,473 | |
Deep
Isolation Nuclear, Inc. and Subsidiaries
Condensed
Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)
(in thousands, except share and per share data)
| | |
Common
Stock | | |
Preferred
Stock Series
A | | |
Preferred
Stock Series
A Prime | | |
Additional Paid
in | | |
Accumulated | | |
Accumulated Other Comprehensive | | |
Total Stockholders’ | |
| | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Income | | |
Equity | |
| Balance,
January 1, 2026 | |
| 57,542,113 | | |
$ | 6 | | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | 59,456 | | |
$ | (32,503 | ) | |
$ | 237 | | |
$ | 27,196 | |
| Exercise
of stock options and distribution of restricted stock units | |
| 105,500 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 4 | | |
| — | | |
| — | | |
| 4 | |
| Stock
based compensation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 522 | | |
| — | | |
| — | | |
| 522 | |
| Foreign
currency translation adjustments | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 48 | | |
| 48 | |
| Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (5,416 | ) | |
| — | | |
| (5,416 | ) |
| Balance,
March 31, 2026 | |
| 57,647,613 | | |
| 6 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 59,982 | | |
| (37,919 | ) | |
| 285 | | |
$ | 22,354 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercise
of stock options and distribution of restricted stock units | |
| 19,500 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
| Stock
based compensation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 363 | | |
| — | | |
| — | | |
| 363 | |
| Foreign
currency translation adjustments | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (15 | ) | |
| (15 | ) |
| Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (3,036 | ) | |
| — | | |
| (3,036 | ) |
| Balance,
June 30, 2026 | |
| 57,667,113 | | |
| 6 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 60,345 | | |
| (40,955 | ) | |
| 270 | | |
| 19,666 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercise
of stock options and distribution of restricted stock units | |
| 59,737 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 11 | | |
| — | | |
| — | | |
| 11 | |
| Stock
based compensation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,888 | | |
| — | | |
| — | | |
| 1,888 | |
| Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (9 | ) | |
| (9 | ) |
| Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (3,764 | ) | |
| — | | |
| (3,764 | ) |
| Balance,
September 30, 2026 | |
| 57,726,850 | | |
$ | 6 | | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | 62,244 | | |
$ | (44,719 | ) | |
$ | 261 | | |
$ | 17,792 | |
Deep
Isolation Nuclear, Inc. and Subsidiaries
Condensed
Consolidated Statements of Cash Flows
(Unaudited)
(in thousands, except share and per share data
| | |
Nine Months Ended September 30, | |
| | |
2026 | | |
2025 | |
| Cash Flows from Operating Activities: | |
| | |
| |
| Net loss | |
$ | (12,216 | ) | |
$ | (2,836 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
| Depreciation and amortization expense | |
| 86 | | |
| 88 | |
| Interest expense | |
| 1 | | |
| 1 | |
| Stock based compensation | |
| 2,773 | | |
| 247 | |
|
Gain on debt extinguishment | |
| — | | |
| (74 | ) |
| Gain on insurance settlement | |
| (27 | ) | |
| — | |
| Changes in operating assets and liabilities: | |
| | | |
| | |
| Accounts receivable | |
| (347 | ) | |
| (499 | ) |
| Allowance for credit losses | |
| 17 | | |
| (17 | ) |
| Contract assets | |
| (598 | ) | |
| (30 | ) |
| Other current assets | |
| (164 | ) | |
| (968 | ) |
| Other non current assets | |
| 68 | | |
| — | |
| Accounts payable | |
| (364 | ) | |
| 605 | |
| Contract liabilities | |
| 75 | | |
| 414 | |
| Accrued expenses | |
| (458 | ) | |
| (174 | ) |
| Other current liabilities | |
| 289 | | |
| 16 | |
| Operating lease right-of-use assets and lease liabilities | |
| (3 | ) | |
| (3 | ) |
| Net cash used in operating activities | |
| (10,868 | ) | |
| (3,230 | ) |
| Cash Flows from Investing Activities: | |
| | | |
| | |
| Purchases of property, plant and equipment | |
| (89 | ) | |
| (38 | ) |
| Proceeds from insurance on disposal of fixed asset | |
| 27 | | |
| — | |
| Cash acquired in reverse acquisition | |
| — | | |
| 7 | |
| Net cash used in investing activities | |
| (62 | ) | |
| (31 | ) |
| Cash Flows from Financing Activities: | |
| | | |
| | |
| Payment of finance lease liability | |
| (3 | ) | |
| — | |
| Proceeds from issuance of Series A Prime Preferred Stock | |
| — | | |
| — | |
| Proceeds from Offering, net of Offering costs | |
| — | | |
| 28,848 | |
| Payment of share repurchase liability | |
| — | | |
| (81 | ) |
| Proceeds from exercise of stock options | |
| 15 | | |
| 434 | |
| Net cash provided by financing activities | |
| 12 | | |
| 29,201 | |
| | |
| | | |
| | |
| Net change in cash and cash equivalents | |
| (10,918 | ) | |
| 25,940 | |
| Effect of exchange rate on cash and cash equivalents | |
| 24 | | |
| 120 | |
| | |
| | | |
| | |
| Cash and cash equivalents: | |
| | | |
| | |
| Beginning of period | |
| 27,434 | | |
| 2,149 | |
| End of period | |
$ | 16,540 | | |
$ | 28,209 | |
| | |
| | | |
| | |
| Supplemental schedule of non-cash investing and financing activities: | |
| | | |
| | |
| Issuance of common stock in reverse acquisition | |
$ | — | | |
$ | 176 | |
Exhibit
II Non-GAAP Financial Measures: EBITDA and Adjusted EBITDA
EBITDA
is defined as earnings before depreciation, amortization, finance income and expense, and taxes. Adjusted EBITDA is defined as EBITDA
before certain items, including registration statement expenses and research and development expenses, that management believes are not
indicative of core ongoing operations for the periods presented. EBITDA and Adjusted EBITDA are non-GAAP financial measures that are
used as supplemental financial measures by management and external users of financial statements, such as investors, to assess our financial
and operating performance. We believe that these non-GAAP financial measures assist our management and investors by increasing the comparability
of our performance from period to period. We believe that including EBITDA and Adjusted EBITDA assists our management and investors in
(i) understanding and analyzing the results of our operating and business performance, (ii) selecting between investing in us and other
investment alternatives and (iii) monitoring our ongoing financial and operational strength in assessing whether to purchase and/or to
continue to hold our common shares. This is achieved by excluding the potentially disparate effects between periods of, in the case of
EBITDA and Adjusted EBITDA, financial income and expenses,, taxes, depreciation and amortization; in the case of Adjusted EBITDA, registration
statement expenses and research and development expenses, which are excluded because they relate to specific, discrete initiatives and
may vary significantly based on the timing and scope of such activities.
EBITDA
and Adjusted EBITDA have limitations as analytical tools and should not be considered as alternatives to, or as substitutes for, or superior
to, profit or loss, profit or loss from operations, earnings or loss per share or any other measure of operating performance presented
in accordance with GAAP. Some of these limitations include the fact that they do not reflect (i) our cash expenditures or future requirements
for capital expenditures or contractual commitments and (ii) changes in, or cash requirements for, our working capital needs. Although
depreciation and amortization are non-cash charges, the assets being depreciated and amortized will have to be replaced in the future,
and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. EBITDA and Adjusted EBITDA are not adjusted
for all non-cash income or expense items that are reflected in our statements of cash flows and other companies in our industry may calculate
these measures differently than we do, limiting their usefulness as a comparative measure.
In
evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as, or similar to, some of
the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results
will be unaffected by the excluded items. Therefore, the non-GAAP financial measures as presented below may not be comparable to similarly
titled measures of other companies in the nuclear or other industries.
The
following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA for each of the periods presented (in thousands):
| | |
For the Three Months Ended | |
| | |
September 30,
2026 | | |
September 30, 2025 | |
| Net loss | |
$ | (3,764 | ) | |
$ | (1,307 | ) |
| Depreciation and amortization expense | |
| 36 | | |
| 29 | |
| Other income (expense) | |
| (91 | ) | |
| (232 | ) |
| Provision for income taxes | |
| — | | |
| — | |
| EBITDA | |
| (3,819 | ) | |
| (1,510 | ) |
| Registration statement expenses (1) | |
| — | | |
| 100 | |
| Research and development expenses (2) | |
| 450 | | |
| — | |
| Adjusted EBITDA | |
$ | (3,369 | ) | |
$ | (1,410 | ) |
| (1) | Represents
specific costs that are incremental and discrete to the periods presented and are not indicative of our core ongoing operations. For
the three months ended September 30, 2025, these amounts were comprised of non-routine legal costs associated with the Company’s
registration statement that do not qualify for equity issuance costs and outside the ordinary course of business. |
| (2) | For
the three months ended September 30, 2026, these amounts were comprised of research and development costs incurred to design, develop,
test, and validate the Company’s technologies and services for the deep borehole disposal of nuclear waste. The Company believes
excluding these investments provides investors with additional insight into the operating performance of its core business activities
and enhances comparability across reporting periods by removing costs that may vary significantly based on the timing and scope of development
initiatives. |